ASCO GU 2023 Upper Tract Urothelial Carcinoma

Viewing 1-5 of 5 articles

ASCO GU 2023: Radical Nephroureterectomy Followed by Adjuvant Chemotherapy Versus Observation in Early-Stage Upper Urinary Tract Cancers with Variant Histology

ASCO GU 2023: Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Patients with Clinically Node-Positive Upper Tract Urothelial Cancer (UTUC) Who Underwent Radical Nephroureterectomy

ASCO GU 2023: Neoadjuvant Nivolumab + Ipilimumab in Cisplatin-Ineligible Patients with Upper Tract Urothelial Cancer

ASCO GU 2023: A SEER-Medicare Based Quality Score for Patients with Synchronous and Metachronous Metastatic Upper Tract Urothelial Carcinoma and Its Association with Cost of Care and Survival

ASCO GU 2023: Oncologic Outcomes in Patients with Residual Invasive Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy